Acinetobacter sp. has emerged as a major hospital pathogen ([8][1]). The greatest concern has been the emergence of carbapenem resistance in Acinetobacter baumannii by the acquisition of OXA-type carbapenemase or metallo-β-lactamases, since few effective antimicrobial agents exist. Several
No takes yet. Share an insight, caveat, or question.
Endo et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: